Cost-Effectiveness Analysis of Eltrombopag As Support Treatment In Chronic Hcv Infected Patients With Thrombocytopenia To Enable Interferon-Based Regimens
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1692
https://www.valueinhealthjournal.com/article/S1098-3015(14)03622-5/fulltext
Title :
Cost-Effectiveness Analysis of Eltrombopag As Support Treatment In Chronic Hcv Infected Patients With Thrombocytopenia To Enable Interferon-Based Regimens
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03622-5&doi=10.1016/j.jval.2014.08.1692
First page :
A532
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1165